0000899243-20-016937.txt : 20200617 0000899243-20-016937.hdr.sgml : 20200617 20200617205552 ACCESSION NUMBER: 0000899243-20-016937 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200615 FILED AS OF DATE: 20200617 DATE AS OF CHANGE: 20200617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kornfeld Steven CENTRAL INDEX KEY: 0001814653 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38052 FILM NUMBER: 20971071 MAIL ADDRESS: STREET 1: C/O FORTE BIOSCIENCES, INC. STREET 2: 1124 W. CARSON ST., MRL BLDG 3-320 CITY: TORRANCE STATE: CA ZIP: 90502 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Forte Biosciences, Inc. CENTRAL INDEX KEY: 0001419041 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261243872 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4242 CAMPUS POINT COURT, SUITE 500 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 412-8400 MAIL ADDRESS: STREET 1: 4242 CAMPUS POINT COURT, SUITE 500 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Tocagen Inc DATE OF NAME CHANGE: 20071120 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-15 0 0001419041 Forte Biosciences, Inc. FBRX 0001814653 Kornfeld Steven C/O FORTE BIOSCIENCES, INC. 1124 W. CARSON STREET, MRL BLDG. 3-320 TORRANCE CA 90502 1 0 0 0 Stock Option (right to buy) 18.90 2020-06-15 4 A 0 30000 0.00 A 2030-06-15 Common Stock 30000 30000 D Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2017 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over a three year period such that the option is fully vested on the third anniversary of the Date of Grant. "Date of Grant" shall mean June 15, 2020. /s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact 2020-06-17